Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Feb-24 10:00 PM View:  | Vitt Daniel President and CEO Director | Vital Therapies, Inc. (IMUX) | 26-Feb-24 | Private Purchase | 14,000 | $1.31 | $18,333.00 | 4% 376.88K to 390.88K | |
| 16-May-23 8:30 AM View: | Whaley Glenn Chief Financial Officer | Vital Therapies, Inc. (IMUX) | 15-May-23 | Private Purchase | 5,000 | $1.75 | $8,750.00 | 24% 20.51K to 25.51K | |
| 15-Dec-22 4:06 PM View: | Neermann Joerg Director | Vital Therapies, Inc. (IMUX) | 14-Dec-22 | Purchase | 47,000 | $1.26 | $59,032.00 | 89% 53.0K to 100.0K | |
| 15-Dec-22 4:06 PM View: | Neermann Joerg Director | Vital Therapies, Inc. (IMUX) | 13-Dec-22 | Private Purchase | 35,000 | $1.25 | $43,610.00 | 194% 18.0K to 53.0K | |
| 25-Nov-22 4:05 PM View: | Neermann Joerg Director | Vital Therapies, Inc. (IMUX) | 23-Nov-22 | Private Purchase | 18,000 | $1.39 | $25,020.00 | 100% 0 to 18.0K | |
| 23-Nov-22 10:13 AM View: | Vitt Daniel President and CEO Director | Vital Therapies, Inc. (IMUX) | 22-Nov-22 | Private Purchase | 8,000 | $1.35 | $10,799.20 | 2% 368.88K to 376.88K | |
| 08-Nov-22 5:48 PM View: | Whaley Glenn Chief Financial Officer | Vital Therapies, Inc. (IMUX) | 07-Nov-22 | Private Purchase | 5,000 | $1.50 | $7,475.00 | 32% 15.51K to 20.51K | |
| 06-Jun-22 8:31 AM View: | Whaley Glenn Chief Financial Officer | Vital Therapies, Inc. (IMUX) | 03-Jun-22 | Private Purchase | 3,500 | $3.05 | $10,657.50 | 39% 9.07K to 12.57K | |
| 06-Jun-22 8:31 AM View: | Vitt Daniel President and CEO Director | Vital Therapies, Inc. (IMUX) | 03-Jun-22 | Private Purchase | 5,000 | $3.10 | $15,499.50 | 1% 363.88K to 368.88K | |
| 16-May-22 8:30 AM View: | Muehler Andreas Chief Medical Officer | Vital Therapies, Inc. (IMUX) | 12-May-22 | Private Purchase | 3,500 | $5.10 | $17,850.00 | 1% 294.49K to 297.99K | |
| 13-May-22 8:31 AM View: | Nash Duane Executive Chairman Director | Vital Therapies, Inc. (IMUX) | 12-May-22 | Gift | 6,000 | -- | -- | (27%) 22.03K to 16.03K | |
| 13-May-22 8:31 AM View: | Nash Duane Executive Chairman Director | Vital Therapies, Inc. (IMUX) | 12-May-22 | Private Purchase | 10,000 | $5.03 | $50,300.00 | 83% 12.03K to 22.03K | |
| 13-May-22 8:31 AM View: | Whaley Glenn Chief Financial Officer | Vital Therapies, Inc. (IMUX) | 12-May-22 | Private Purchase | 3,000 | $5.08 | $15,240.00 | 49% 6.07K to 9.07K | |
| 03-Jan-22 10:00 PM View: | Nash Duane Executive Chairman Director | Vital Therapies, Inc. (IMUX) | 08-Nov-21 | Gift | 3,000 | -- | -- | (20%) 15.03K to 12.03K | |
| 11-Aug-21 9:02 AM View: | Nash Duane Executive Chairman Director | Vital Therapies, Inc. (IMUX) | 10-Aug-21 | Market Purchase | 1,000 | $9.80 | $9,800.00 | 7% 14.03K to 15.03K | (< 1%) |
| 11-Aug-21 9:04 AM View: | Vitt Daniel President and CEO Director | Vital Therapies, Inc. (IMUX) | 10-Aug-21 | Market Purchase | 1,000 | $9.60 | $9,600.00 | < 1% 362.88K to 363.88K | 2% |
| 11-Aug-21 9:05 AM View: | Whaley Glenn PFO and PAO | Vital Therapies, Inc. (IMUX) | 10-Aug-21 | Market Purchase | 1,500 | $9.85 | $14,775.00 | 75% 2.0K to 3.5K | (< 1%) |
| 12-May-21 4:31 PM View: | Nash Duane Executive Chairman Director | Vital Therapies, Inc. (IMUX) | 12-May-21 | Market Purchase | 4,000 | $12.75 | $51,000.00 | 40% 10.03K to 14.03K | 8% |
| 03-Mar-21 4:31 PM View: | Whaley Glenn PFO and PAO | Vital Therapies, Inc. (IMUX) | 02-Mar-21 | Market Purchase | 1,000 | $16.48 | $16,480.00 | 100% 1.0K to 2.0K | (16%) |
| 15-Mar-21 5:05 PM View: | Muehler Andreas Chief Medical Officer | Vital Therapies, Inc. (IMUX) | 02-Mar-21 | Market Purchase | 10,006 | $15.54 | $155,493.00 | 4% 284.48K to 294.49K | (11%) |
| 10-Aug-20 5:15 PM View: | Whaley Glenn PFO and PAO | Vital Therapies, Inc. (IMUX) | 10-Aug-20 | Market Purchase | 1,000 | $18.96 | $18,960.00 | 100% 0 to 1.0K | (27%) |
| 22-Jul-20 4:06 PM View: | Groeppel Manfred Chief Operating Officer | Vital Therapies, Inc. (IMUX) | 21-Jul-20 | Market Sale (Planned) | 650 | $15.62 | $10,154.90 | (< 1%) 279.48K to 278.83K | 12% |
| 22-Jul-20 4:05 PM View: | Vitt Daniel Chief Executive Officer Director | Vital Therapies, Inc. (IMUX) | 21-Jul-20 | Market Sale (Planned) | 1,300 | $15.62 | $20,309.80 | (< 1%) 364.18K to 362.88K | 12% |
| 22-Jul-20 4:05 PM View: | Vitt Daniel Chief Executive Officer Director | Vital Therapies, Inc. (IMUX) | 20-Jul-20 | Market Sale (Planned) | 5,000 | $14.44 | $72,200.50 | (1%) 369.18K to 364.18K | 4% |
| 22-Jul-20 4:06 PM View: | Groeppel Manfred Chief Operating Officer | Vital Therapies, Inc. (IMUX) | 20-Jul-20 | Market Sale (Planned) Duplicate | 5,000 | $14.44 | $72,200.50 | (2%) 284.48K to 279.48K | 4% |
| 04-Dec-19 7:00 PM View: | Nash Duane Director | Vital Therapies, Inc. (IMUX) | 04-Dec-19 | Market Option Sale (Planned) | 4,400 | $6.96 | $30,624.00 | (30%) 14.43K to 10.03K | (99%) |
| 04-Dec-19 7:00 PM View: | Nash Duane Director | Vital Therapies, Inc. (IMUX) | 03-Dec-19 | Payment of Exercise | 7,930 | $7.15 | $56,732.00 | (35%) 22.36K to 14.43K | (93%) |
| 04-Dec-19 7:00 PM View: | Nash Duane Director | Vital Therapies, Inc. (IMUX) | 02-Dec-19 | Option Exercise | 22,157 | -- | -- | 10808% 0.2K to 22.36K | |
| 25-Sep-18 7:28 PM View: | Halperin Errol R. Director | Vital Therapies, Inc. (IMUX) | 25-Sep-18 | Market Sale | 10,000 | $0.29 | $2,900.00 | (100%) 10.0K to 0 | (34%) |
| 25-Sep-18 7:28 PM View: | Halperin Errol R. Director | Vital Therapies, Inc. (IMUX) | 25-Sep-18 | Market Sale | 89,417 | $0.29 | $25,939.90 | (90%) 99.42K to 10.0K | (34%) |
| 24-Sep-18 7:24 PM View: | Bienaime Jean Jacques Director | Vital Therapies, Inc. (IMUX) | 24-Sep-18 | Market Sale | 26,619 | $0.30 | $8,001.67 | (59%) 45.12K to 18.5K | (27%) |
| 21-Sep-18 4:19 PM View: | Godshall Douglas Evan Director | Vital Therapies, Inc. (IMUX) | 19-Sep-18 | Market Sale | 69,375 | $0.35 | $24,191.10 | (100%) 69.38K to 0 | (13%) |
| 17-Sep-18 9:30 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 17-Sep-18 | Market Sale | 7,044,780 | $0.29 | $2,054,260.00 | (33%) 21.58M to 14.54M | (33%) |
| 17-Sep-18 9:30 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 14-Sep-18 | Market Sale | 447,500 | $0.36 | $160,384.00 | (2%) 22.03M to 21.58M | (9%) |
| 17-Sep-18 9:30 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 13-Sep-18 | Market Sale | 3,890,000 | $0.50 | $1,931,000.00 | (15%) 25.92M to 22.03M | 21% |
| 17-Sep-18 9:24 PM View: | Bienaime Jean Jacques Director | Vital Therapies, Inc. (IMUX) | 13-Sep-18 | Market Sale | 20,000 | $0.47 | $9,400.00 | (31%) 65.12K to 45.12K | 16% |
| 17-Sep-18 9:26 PM View: | Hasnain Faheem Director | Vital Therapies, Inc. (IMUX) | 13-Sep-18 | Market Sale | 177,443 | $0.44 | $77,678.60 | (96%) 185.44K to 8.0K | 10% |
| 14-Sep-18 4:08 PM View: | Cohen Cheryl Director | Vital Therapies, Inc. (IMUX) | 12-Sep-18 | Market Sale | 3,500 | $0.55 | $1,925.00 | (100%) 3.5K to 0 | 29% |
| 14-Dec-17 6:47 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 13-Dec-17 | Market Purchase | 50,000 | $5.57 | $278,570.00 | < 1% 11.33M to 11.38M | (93%) |
| 14-Dec-17 6:47 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 12-Dec-17 | Market Purchase | 50,000 | $5.40 | $269,765.00 | < 1% 11.28M to 11.33M | (93%) |
| 11-Dec-17 5:35 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 11-Dec-17 | Market Purchase | 50,000 | $4.96 | $248,225.00 | < 1% 11.23M to 11.28M | (92%) |
| 11-Dec-17 5:35 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 08-Dec-17 | Market Purchase | 50,000 | $4.92 | $246,185.00 | < 1% 11.18M to 11.23M | (92%) |
| 11-Dec-17 5:35 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 07-Dec-17 | Market Purchase | 50,000 | $4.77 | $238,730.00 | < 1% 11.13M to 11.18M | (92%) |
| 14-Sep-17 7:40 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 14-Sep-17 | Market Purchase | 30,000 | $4.25 | $127,539.00 | < 1% 11.1M to 11.13M | (91%) |
| 15-Sep-17 4:19 PM View: | Hasnain Faheem Director | Vital Therapies, Inc. (IMUX) | 14-Sep-17 | Market Purchase | 59,200 | $4.19 | $247,870.00 | 47% 126.24K to 185.44K | (91%) |
| 14-Sep-17 4:15 PM View: | Bienaime Jean Jacques Director | Vital Therapies, Inc. (IMUX) | 13-Sep-17 | Market Purchase | 10,000 | $4.00 | $39,969.00 | 18% 55.12K to 65.12K | (90%) |
| 14-Sep-17 7:40 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 13-Sep-17 | Market Purchase | 50,000 | $4.13 | $206,465.00 | < 1% 11.05M to 11.1M | (90%) |
| 14-Sep-17 7:40 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 12-Sep-17 | Market Purchase | 50,000 | $3.74 | $187,225.00 | < 1% 11.0M to 11.05M | (89%) |
| 12-Sep-17 4:14 PM View: | Satter Muneer A Director 10% Owner | Vital Therapies, Inc. (IMUX) | 08-Sep-17 | Market Purchase | 50,000 | $3.53 | $176,615.00 | < 1% 10.95M to 11.0M | (89%) |
| 15-Jun-17 4:29 PM View: | Dunn John Michael General Counsel and Secretary | Vital Therapies, Inc. (IMUX) | 14-Jun-17 | Market Purchase | 2,500 | $3.09 | $7,724.46 | 27% 9.38K to 11.88K | (87%) |
